Adverse Reactions to Immunotherapy Can Appear After a Year

Clinicians should be on the lookout for immune-related adverse reactions (irAEs) even after patients have been receiving anti–programmed cell death […]

» Read more

Deadly Brain Tumor: Survival Extended by Oncolytic Virus Product

An experimental immunotherapy that contains a genetically altered version of herpes simplex virus type 1 (HSV-1) was associated with a […]

» Read more

First Drug That Protects Against Chemo-Induced Myelosuppression

A novel drug that offers multilineage protection from chemotherapy-induced myelosuppression has been approved by the US Food and Drug Administration. […]

» Read more
1 2 3